Question 1

What is LOPJLB’s current signal on RNXT?

Accepted Answer

LOPJLB’s latest quantitative signal on RenovoRx, Inc. (RNXT) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is RNXT in?

Accepted Answer

RenovoRx, Inc. (RNXT) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does RenovoRx, Inc. (RNXT) do?

Accepted Answer

RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced …

Question 4

Where is RenovoRx, Inc. based / listed?

Accepted Answer

RenovoRx, Inc. is based in US, listed on NASDAQ.

RenovoRx, Inc. (RNXT)

Key stats

Prediction markets

Company news